Dr. Andrew Quest’s Book Addresses Caveolin-1’s Dual Role in Cancer – Amazon Books

In biology, few stories are as intriguing as that of Caveolina-1. Ally against cancer or accomplice to its advance? In Caveolin-1: A Double-Edged Sword in Cancer, Dr. Andrew Quest reveals how the same protein can play completely opposite roles depending on the cellular context.

The scientific community has a new reference work to understand one of the most complex phenomena in tumour biology. Dr. Andrew Quest has published on Amazon a book that analyzes the contradictory role of the protein Caveolin-1 (CAV1) in the development and progression of cancer.

Based on more than three decades of research, the book examines how the same protein can act as a tumour suppressor in certain circumstances and, in other contexts, promote cell invasion, metastasis and disease progression. The text delves into mechanisms related to cell signaling, metabolic regulation, cell migration and intercellular communication, offering an integrative view of the role of CAV1 in cancer biology.

Aimed at graduate students, researchers, clinicians, and readers interested in the biomedical sciences, the book combines scientific rigor with an accessible approach, allowing us to understand how the cellular context can radically modify the function of a key molecule.

With this publication, Dr. Quest presents an updated synthesis of the most relevant advances in the study of Caveolin-1, highlighting both its biological implications and its potential interest for the development of future therapeutic strategies against cancer.

Caveolin-1: A Double-Edged Sword in Cancer:
From Tumor Suppressor to Metastasis Driver

Available in print on Amazon Books.